Role of Monoclonal Antibody "Alemtuzumab" in the Treatment of Multiple Sclerosis

This article will review current treatment options for multiple sclerosis (MS) while keeping our primary focus on alemtuzumab, as it is now approved in more than 65 countries. From a pathophysiological point of view, MS is a disabling disease impacting a patient's life both physically and menta...

Descripción completa

Detalles Bibliográficos
Autores principales: Nosher, Sadia, Fuad, Sehrish, Mishra, Nupur, Alrashid, Zaid A, Rathod, Bindu, Mohan, Devyani, Basavanagowda, Deepak M, Kaur, Arveen, Heindl, Stacey E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Family/General Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948316/
https://www.ncbi.nlm.nih.gov/pubmed/33728194
http://dx.doi.org/10.7759/cureus.13246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948316/
https://www.ncbi.nlm.nih.gov/pubmed/33728194
http://dx.doi.org/10.7759/cureus.13246

Ejemplares similares